TY - JOUR T1 - Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy JF - medRxiv DO - 10.1101/2020.07.19.20152322 SP - 2020.07.19.20152322 AU - Claudia Alteri AU - Valeria Cento AU - Antonio Piralla AU - Valentino Costabile AU - Monica Tallarita AU - Luna Colagrossi AU - Silvia Renica AU - Federica Giardina AU - Federica Novazzi AU - Stefano Gaiarsa AU - Elisa Matarazzo AU - Maria Antonello AU - Chiara Vismara AU - Roberto Fumagalli AU - Oscar Massimiliano Epis AU - Massimo Puoti AU - Carlo Federico Perno AU - Fausto Baldanti Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/20/2020.07.19.20152322.abstract N2 - From February to April, 2020, Lombardy (Italy) was the area who worldwide registered the highest numbers of SARS-CoV-2 infection. By extensively analyzing 346 whole SARS-CoV-2 genomes, we demonstrated the simultaneous circulation in Lombardy of two major viral lineages, likely derived from multiple introductions, occurring since the second half of January. Seven single nucleotide polymorphisms (five of them non-synonymous) characterized the SARS-CoV-2 sequences, none of them affecting N-glycosylation sites. These two lineages, and the presence of two well defined clusters inside Lineage 1, revealed that a sustained community transmission was ongoing way before the first COVID-19 case found in Lombardy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was financially supported by an unrestricted grant from Cariplo foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by local Research Ethics Committee of the two hospitals (prot. 92-15032020 and P_20200029440). This study was conducted in accordance with the principles of the 1964 Declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCorresponding author is Carlo Federico Perno, MD, PhD, University of Milan, email: cf.perno@uniroma2.it. The data that support the findings of this study are available from the corresponding author upon reasonable request. ER -